KINASET THERAPEUTICS Trademark

Trademark Overview

On Monday, December 14, 2020, a trademark application was filed for KINASET THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the KINASET THERAPEUTICS trademark a serial number of 90381025. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, January 11, 2024. This trademark is owned by Kinaset Therapeutics, Inc.. The KINASET THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic agents and pharmaceuticals for treating and preventing respiratory and inflammatory conditions and diseases
kinaset therapeutics

General Information

Serial Number90381025
Word MarkKINASET THERAPEUTICS
Filing DateMonday, December 14, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, January 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements

Goods and ServicesTherapeutic agents and pharmaceuticals for treating and preventing respiratory and inflammatory conditions and diseases
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKinaset Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMedfield, MA 02052
Party NameKinaset Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMedfield, MA 02052

Trademark Events

Event DateEvent Description
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024SOU EXTENSION 4 GRANTED
Thursday, January 11, 2024SOU EXTENSION 4 FILED
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 28, 2023SOU EXTENSION 3 GRANTED
Monday, August 28, 2023SOU EXTENSION 3 FILED
Monday, August 28, 2023SOU TEAS EXTENSION RECEIVED
Saturday, January 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2023SOU EXTENSION 2 GRANTED
Thursday, January 26, 2023SOU EXTENSION 2 FILED
Thursday, January 26, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 23, 2022CORRECTED NOA E-MAILED
Thursday, September 22, 2022SOU EXTENSION 1 GRANTED
Tuesday, September 6, 2022SOU EXTENSION 1 FILED
Thursday, September 22, 2022DIVISIONAL PROCESSING COMPLETE
Tuesday, September 6, 2022DIVISIONAL REQUEST RECEIVED
Wednesday, September 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 6, 2022TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, September 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 20, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 2, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, December 2, 2021ASSIGNED TO LIE
Thursday, December 2, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 2, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, December 2, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 15, 2021NON-FINAL ACTION E-MAILED
Tuesday, June 15, 2021NON-FINAL ACTION WRITTEN
Saturday, June 5, 2021ASSIGNED TO EXAMINER
Monday, February 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 17, 2020NEW APPLICATION ENTERED

Related Keywords

therapeutics kinaset inflammatory conditions diseases respiratory preventing agents pharmaceuticals treating therapeutic